Cite
HARVARD Citation
Versluis, J. et al. (2021). Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma. European journal of cancer. pp. 51-57. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Versluis, J. et al. (2021). Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma. European journal of cancer. pp. 51-57. [Online].